Cargando…

Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial

OBJECTIVE: Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical intensive care units. The aim of this study is to assess the effect of IIT using a closed-loop system in hepatectomized patients. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive...

Descripción completa

Detalles Bibliográficos
Autores principales: Okabayashi, Takehiro, Nishimori, Isao, Maeda, Hiromichi, Yamashita, Koichi, Yatabe, Tomoaki, Hanazaki, Kazuhiro
Formato: Texto
Lenguaje:English
Publicado: American Diabetes Association 2009
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713620/
https://www.ncbi.nlm.nih.gov/pubmed/19435954
http://dx.doi.org/10.2337/dc08-2107
_version_ 1782169588745633792
author Okabayashi, Takehiro
Nishimori, Isao
Maeda, Hiromichi
Yamashita, Koichi
Yatabe, Tomoaki
Hanazaki, Kazuhiro
author_facet Okabayashi, Takehiro
Nishimori, Isao
Maeda, Hiromichi
Yamashita, Koichi
Yatabe, Tomoaki
Hanazaki, Kazuhiro
author_sort Okabayashi, Takehiro
collection PubMed
description OBJECTIVE: Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical intensive care units. The aim of this study is to assess the effect of IIT using a closed-loop system in hepatectomized patients. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive IIT using a closed-loop system: an artificial pancreas (AP group) or conventional insulin therapy using the sliding-scale method (SS group). RESULTS: The incidence of surgical-site infection in the AP group was significantly lower than that in the SS group. The length of hospitalization required for patients in the AP group was significantly shorter than that in the SS group. CONCLUSIONS: Total hospital costs for patients in the AP group were significantly lower than for patients in the SS group. IIT using a closed-loop system maintained near-normoglycemia and contributed to a reduction in the incidence of SSI and total hospital costs due to shortened hospitalization.
format Text
id pubmed-2713620
institution National Center for Biotechnology Information
language English
publishDate 2009
publisher American Diabetes Association
record_format MEDLINE/PubMed
spelling pubmed-27136202010-08-01 Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial Okabayashi, Takehiro Nishimori, Isao Maeda, Hiromichi Yamashita, Koichi Yatabe, Tomoaki Hanazaki, Kazuhiro Diabetes Care Original Research OBJECTIVE: Intensive insulin therapy (IIT) reduces morbidity and mortality in patients in surgical intensive care units. The aim of this study is to assess the effect of IIT using a closed-loop system in hepatectomized patients. RESEARCH DESIGN AND METHODS: Patients were randomly assigned to receive IIT using a closed-loop system: an artificial pancreas (AP group) or conventional insulin therapy using the sliding-scale method (SS group). RESULTS: The incidence of surgical-site infection in the AP group was significantly lower than that in the SS group. The length of hospitalization required for patients in the AP group was significantly shorter than that in the SS group. CONCLUSIONS: Total hospital costs for patients in the AP group were significantly lower than for patients in the SS group. IIT using a closed-loop system maintained near-normoglycemia and contributed to a reduction in the incidence of SSI and total hospital costs due to shortened hospitalization. American Diabetes Association 2009-08 2009-05-12 /pmc/articles/PMC2713620/ /pubmed/19435954 http://dx.doi.org/10.2337/dc08-2107 Text en © 2009 by the American Diabetes Association. https://creativecommons.org/licenses/by-nc-nd/3.0/Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. See http://creativecommons.org/licenses/by-nc-nd/3.0/ (https://creativecommons.org/licenses/by-nc-nd/3.0/) for details.
spellingShingle Original Research
Okabayashi, Takehiro
Nishimori, Isao
Maeda, Hiromichi
Yamashita, Koichi
Yatabe, Tomoaki
Hanazaki, Kazuhiro
Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
title Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
title_full Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
title_fullStr Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
title_full_unstemmed Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
title_short Effect of Intensive Insulin Therapy Using a Closed-Loop Glycemic Control System in Hepatic Resection Patients: A prospective randomized clinical trial
title_sort effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial
topic Original Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2713620/
https://www.ncbi.nlm.nih.gov/pubmed/19435954
http://dx.doi.org/10.2337/dc08-2107
work_keys_str_mv AT okabayashitakehiro effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial
AT nishimoriisao effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial
AT maedahiromichi effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial
AT yamashitakoichi effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial
AT yatabetomoaki effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial
AT hanazakikazuhiro effectofintensiveinsulintherapyusingaclosedloopglycemiccontrolsysteminhepaticresectionpatientsaprospectiverandomizedclinicaltrial